Cargando…
CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1
Autores principales: | Apgar, J.F., Tang, J.P., Singh, P., Balasubramanian, N., Burke, J.M., Hodges, M.R., Lasaro, M.A., Lin, L., Millard, B.L., Moore, K., Jun, L.S., Sobolov, S., Wilkins, A.K., Gao, X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080543/ https://www.ncbi.nlm.nih.gov/pubmed/32187857 http://dx.doi.org/10.1002/psp4.12484 |
Ejemplares similares
-
Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1
por: Apgar, Joshua F., et al.
Publicado: (2018) -
Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
por: Collaud, Fanny, et al.
Publicado: (2018) -
Crigler-Najjar syndrome type 2: Novel UGT1A1 mutation
por: Nair, Karippoth Mohandas, et al.
Publicado: (2012) -
Novel combined UGT1A1 mutations in Crigler Najjar Syndrome type I
por: Abdellaoui, Nawel, et al.
Publicado: (2022) -
Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II
por: Li, Lufeng, et al.
Publicado: (2015)